Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Denis Chem Lab Ltd (537536)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 537536 NSE: Pharmaceuticals & Drugs | Small Cap | Denis Chem Lab Share Price
₹69.54 -0.17 (-0.24%)
As on 23-Sep'26 11:11
Denis Chem Lab Ltd (537536)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 537536 NSE: Pharmaceuticals & Drugs | Small Cap | Denis Chem Lab Share Price
₹69.54 -0.17 (-0.24%)
As on 23-Sep'26 11:11
Key Metrics
Valuation Multiples
Market Cap
₹97 Cr.
Current Price
₹69.5
52-Week Low / High
₹56 / 98
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
54.8
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
4.86%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
38.98%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹13.9 Cr.
Face Value
₹10
All Time Low / High
₹16.26 / 232.90
Check Before You Invest
M-Cap below 100cr DeciZen not available
Is Denis Chem Lab Ltd a good quality company?
Denis Chem Lab Ltd is a quality company, based on a multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Denis Chem Lab Ltd performance compare with that of its Peers?
Revenue growth of Denis Chem Lab Ltd vs industry peers?
Denis Chem Lab Ltd revenue CAGR is %, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of Denis Chem Lab Ltd?
Promoters hold 38.98% of the Denis Chem Lab Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Denis Chem Lab Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of -3.4% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Denis Chem Lab Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 12.2% | 9.4% | 11.9% | 11.3% | 6.5% | 13.8% | 16.1% | 20.2% | 13.9% | 14% | - |
| Value Creation Index ⓘ | -0.1 | -0.3 | -0.2 | -0.2 | -0.5 | 0.0 | 0.2 | 0.4 | 0.0 | 0 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 113 | 107 | 124 | 136 | 109 | 137 | 161 | 168 | 173 | 182 | 182 |
| Sales YoY Gr. | - | -5.4% | 15.8% | 9.7% | -19.7% | 24.9% | 17.8% | 4.3% | 3.3% | 4.9% | - |
| Adj EPS ⓘ | 0.9 | 1.6 | 4.1 | 3 | 1.6 | 4.5 | 5.7 | 8 | 5.8 | 6.1 | 5.8 |
| YoY Gr. | - | 80.2% | 149.4% | -25.9% | -45.9% | 174.4% | 25.8% | 42.1% | -27.7% | 4.3% | - |
| BVPS (₹) ⓘ | 24.1 | 36 | 40.7 | 42.6 | 44.3 | 47.9 | 52.1 | 57.9 | 61.3 | 66 | 67.5 |
| Adj Net Profit ⓘ | 1.1 | 2.3 | 5.7 | 4.2 | 2.3 | 6.3 | 7.9 | 11.2 | 8.1 | 8.4 | 8 |
| Cash Flow from Ops. ⓘ | 6.8 | 10.6 | 8 | 13.4 | 8 | 17.1 | 16.3 | 17.8 | 12.1 | 4.1 | - |
| Debt/CF from Ops. ⓘ | 5.5 | 2.4 | 2.9 | 1 | 1.1 | 0.2 | 0.1 | 0.1 | 0.1 | 1 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 5.4% | 10.7% | 4.2% | 4.9% | ||||
| Adj EPS ⓘ | 23.5% | 29.9% | 2.3% | 4.3% | ||||
| BVPSⓘ | 11.9% | 8.3% | 8.2% | 7.6% | ||||
| Share Price | -3.3% | 0.9% | -13% | -28.7% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 4.9 | 5.7 | 10.7 | 7.3 | 3.8 | 9.8 | 11.3 | 14.6 | 9.8 | 9.5 | 8.6 |
| Op. Profit Mgn % ⓘ | 12.3 | 11.4 | 11.2 | 11 | 9.4 | 10.5 | 11.7 | 12.7 | 9.3 | 9.7 | 9.1 |
| Net Profit Mgn % ⓘ | 1 | 2.1 | 4.6 | 3.1 | 2.1 | 4.6 | 4.9 | 6.7 | 4.7 | 4.6 | 4.4 |
| Debt to Equity ⓘ | 1.3 | 0.5 | 0.4 | 0.2 | 0.1 | 0.1 | 0 | 0 | 0 | 0.1 | - |
| Working Cap Days ⓘ | 114 | 146 | 139 | 131 | 157 | 123 | 103 | 99 | 98 | 106 | 81 |
| Cash Conv. Cycle ⓘ | 24 | 36 | 53 | 66 | 80 | 59 | 44 | 40 | 37 | 42 | 49 |
Valuation of Denis Chem Lab - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Denis Chem Lab Ltd FAQs
The current trading price of Denis Chem Lab on 23-Sep-2026 11:11 is ₹69.54.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 22-Sep-2026 the market cap of Denis Chem Lab stood at ₹96.73 Cr
The latest P/E ratio of Denis Chem Lab as of 22-Sep-2026 is 12.13.
The latest P/B ratio of Denis Chem Lab as of 22-Sep-2026 is 1.03.
The 52-week high of Denis Chem Lab is ₹98.00 and the 52-week low is ₹56.10.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Denis Chem Lab is ₹182 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Denis Chem Lab Ltd is a below average quality company.
The key valuation ratios of Denis Chem Lab Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Denis Chem Lab Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Denis Chem Lab Ltd
Denis Chem Lab is a Public Limited Pharmaceutical Company incorporated in 1982. It started commercial production for sterile Intravenous injectibles in 1984. Since more than 30 years it has been actively delivering high quality sterile Intravenous injectibles and contributing in saving lives. It Manufactures and market sterile Intravenous injectibles in Both Glass and Plastic Bottles.
The company’s manufacturing facilities are located in a pollution free environment near Ahmedabad, Gujarat. The Manufacturing facilities are located on a land area of about 14000 sq. metres, the built up area for the manufacturing operations is about 7000 sq.m.
Its manufacturing facilities have been approved by the Foods and Drugs Control Administration Authority (FDCA), Gujarat & WHO GMP. It has also been approved by international bodies, includes FDCA Ivory Cost, Ministry of Health-Vietnam, Ministry of Health-Combodia.
Business area of the company
The company is engaged in the business of manufacturing of Pharmaceuticals Transfusion Solution in Bottles. It offers wide range of sterile intravenous injectables for human and veterinary consumption. The company’s product offerings comprise of various products sold across several states in India. It also exports sterile intravenous medicines to countries like Sri Lanka, Nepal, Combodia, Vietnam, Somalia, Ivory Cost etc. In addition to manufacturing its own products which it sells under its own brands, it does manufacture products on contract basis for third parties including certain multinational pharmaceutical companies who market such products under their own brands.
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
